Access Granted: How Vascular Access Teams Are Revolutionizing Patient Care
"Discover the critical role of vascular access teams in improving patient outcomes, reducing infections, and streamlining healthcare costs."
Hospital-acquired infections are a significant and frequent complication in healthcare, posing a serious risk to patient safety. Data from Italy in 2011 underscored the critical need to address these infections, which are directly correlated with healthcare assistance. These infections not only endanger patients but also place a substantial burden on healthcare systems.
Specifically, the data revealed that for every 100 patients admitted to a hospital, approximately 6.3% acquired an infection attributable to the clinical setting. This alarming rate climbed to 14.8% in intensive care units and affected 13% of patients with rapidly fatal conditions, according to the McCabe classification. Patients with invasive devices were particularly vulnerable, with 21.4% of those with central venous catheters and 13% of those with urinary catheters experiencing infections.
The most frequently reported infections included respiratory infections (24.1%), urinary tract infections (20.8%), surgical site infections (16%), and bacteremia (15.8%). This increase in hospital-acquired infections is a consequence of technological advancements in healthcare. While these innovations allow for the survival of high-risk patients, they also facilitate the entry of microorganisms into normally sterile body sites through devices such as central venous catheters (CVCs), pacemakers, prostheses, and urinary catheters.
VASTs and Standard Practice
A systematic review examined whether vascular access specialist teams (VASTs) improve vascular access device cannulation success and reduce adverse events during intravenous therapy for hospitalized adults. The review used Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. VASTs are presented as a potential way to improve patient health, reduce catheterization discomfort, and enhance satisfaction, but the supplied sources do not establish these benefits as definitive.
The Power of Dedicated Vascular Access Teams
To combat these challenges, healthcare facilities are increasingly adopting safe care practices aimed at preventing and controlling the transmission of infections both within hospitals and in non-hospital settings. Implementing control programs at various levels, from national to local, is essential. The adoption of standardized protocols and procedures (often referred to as bundles), developed based on scientific evidence, helps to regulate and standardize effective activities that reduce the risk of infection.
- Reduced Infection Rates: Implementation of vascular access teams has led to a significant reduction in infection rates associated with CVCs and other vascular access devices.
- Improved Patient Outcomes: Patients experience fewer complications, shorter hospital stays, and an overall enhanced quality of life.
- Cost Savings: By preventing infections and complications, vascular access teams contribute to significant cost savings for healthcare facilities.
- Enhanced Staff Competence: Nurses and medical staff receive specialized training, leading to improved skills and knowledge in vascular access management.
- Standardized Practices: Vascular access teams ensure consistent and evidence-based practices, reducing variability in care and improving reliability.
Evidence and Individualized Access Decisions
Only three studies in the cited systematic review analyzed a main outcome comparing VAST activity with a comparator or control, prompting a secondary analysis of intervention effectiveness. A separate review concluded that high-quality evidence is insufficient to support or reject implementing a VAST. For hemodialysis access, the UK Kidney Association guideline notes that mortality alone is not an adequate basis for access advice, while the optimal initial permanent access for elderly patients remains controversial and depends on factors including comorbidities, life expectancy, and duration of catheter dependence.
Reported Differences in Access Outcomes
The CMS ESRD Vascular Access TEP Summary Report states that 63% of prevalent US dialysis patients use an arteriovenous fistula as regular dialysis access under the Fistula First, Catheter Last initiative. In a study of a vascular access team, central line utilization decreased by 45.2% and central line-associated bloodstream infection incidence decreased by 90%. A randomized controlled trial found signs or symptoms of inflammation in 21.7% of patients whose catheters were started by house staff and maintained by ward nurses, compared with 7.9% among patients whose catheters were maintained by an IV team (P<.001).
The Future of Vascular Access Teams
The implementation of vascular access teams represents a pivotal step toward improving patient care, reducing healthcare costs, and fostering a culture of continuous improvement. As healthcare systems continue to evolve, the role of these specialized teams will undoubtedly expand, driving further advancements in patient safety and quality of care.
Market Forecasts and Global Questions
A market report projects that the vascular access market will reach $5.92 billion by 2025 and discusses trends and forecasts for 2026–2034. A 2022 global outlook article says specialized vascular access training organized into teams was shown to improve patient outcomes, clinical efficiency, and cost savings, while global perspectives on VAT benefits, organization, challenges, and opportunities remain inadequately explored. Another supplied source reports that up to 90% of hospitalized patients undergo catheter placement, underscoring the scale of vascular access use.
Perspectives on VATs in Practice
Morrow et al. (2022) explored the global vascular access team landscape through detailed perspectives. The work addressed challenges, clinical and clinico-economic impacts, and underresearched aspects of team initiation, data dissemination, and measures or benchmarks for success. The supplied source describes these as areas explored in the study rather than providing specific outcome figures.